PharmaCorp Rx Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '25 May 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	53	63	4	12	-
Market Cap Growth	1262.97%	1386.88%	-64.51%	-	-
Enterprise Value	41	38	2	9	-
Last Close Price	0.46	0.54	0.21	0.60	-
PS Ratio	5.41	10.93	-	-	-
PB Ratio	1.72	2.07	1.87	4.42	-
P/TBV Ratio	3.76	4.61	1.87	4.42	-
P/FCF Ratio	129.35	536.24	-	-	-
P/OCF Ratio	119.50	506.68	-	-	-
EV/Sales Ratio	4.21	6.54	-	-	-
EV/FCF Ratio	100.60	320.84	-	-	-
Debt / Equity Ratio	0.03	0.03	-	-	-
Debt / FCF Ratio	2.23	8.07	-	-	-
Asset Turnover	0.52	0.31	-	-	-
Quick Ratio	7.63	7.79	48.54	166.01	37.20
Current Ratio	8.58	8.59	50.24	166.01	37.98
Return on Equity (ROE)	-3.61%	-6.40%	-18.85%	-28.02%	-
Return on Assets (ROA)	-3.77%	-5.29%	-14.29%	-18.85%	-
Return on Capital (ROIC)	-4.19%	-5.88%	-14.47%	-19.07%	-
Earnings Yield	-1.07%	-1.60%	-11.05%	-4.31%	-
FCF Yield	0.77%	0.19%	-12.20%	-1.00%	-
Buyback Yield / Dilution	-397.97%	-303.02%	-1.39%	-23.69%	-

Updated Nov 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.